Skip to main content
Premium Trial:

Request an Annual Quote

Waters Posts 15-Percent Surge in Q3 Sales; US, Asia Markets Help Growth

NEW YORK, Oct. 26 (GenomeWeb News) - Waters today reported a 15-percent spike in third-quarter sales across its product portfolio, resulting in increased revenues and earnings.


Total receipts for the quarter ended Sept. 30 totaled $264.8 million, up from $230.4 million during the same period one year ago. These results reflect strong demand from US and Asian pharma and industry for all Waters product, as well as improved business conditions in Europe, according to the company.


Third-quarter R&D spending increased to $17 million from $15.1 million last year.


Waters' net income for the quarter increased to $51.9 million, or $.43 per basic share, from $36.4 million, or $.30 per basic share.


As of Oct. 2, Waters had $471.2 million in cash and cash equivalents.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.